Romedahl MedScience ApS: Financial statements 2024
CVR: 38540580
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Romedahl MedScience ApS (CVR 38540580) has filed annual accounts for 2024. In 2024, the company reported a net result of DKK -6,398 compared with DKK -6,089 the year before. Equity in the 2024 report amounted to DKK 9,194. The solvency ratio was 29.8%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -6,398
- Equity
- DKK 9,194
- Total Assets
- DKK 30,886
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | -6K | 9K | 1 |
| 2023 | - | - | -6K | 16K | 1 |
| 2022 | - | - | -5K | 22K | 1 |
| 2021 | - | - | -8K | 27K | 1 |
| 2020 | - | - | -9K | -5K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Romedahl MedScience ApS has published its annual report for 2023. The net result was DKK -6,089.
About Romedahl MedScience ApS
Romedahl MedScience ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Romedahl MedScience IVS. The management consists of Hanne Risager Romedahl. The company is owned by Hanne Risager Romedahl. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -8,552 compared with DKK -6,398 the year before. Equity in the 2025 report amounted to DKK 642.